MOTS-c is a mitochondrial-derived peptide (MDP) composed of 16 amino acids, which plays a critical role in cellular metabolic regulation. Synthesized within mitochondria, MOTS-c functions by modulating the cellular energy balance through pathways involved in glucose metabolism, insulin sensitivity, and cellular stress response.  MOTS-c exerts its effects by translocating to the nucleus, where it influences the expression of genes related to mitochondrial biogenesis and metabolic regulation, particularly under conditions of metabolic stress. Research has shown this peptide to improve exercise capacity, reduce obesity, insulin resistance and other disease processes such as osteoporosis and the mitigation of metabolic disorders and age-associated diseases.

Humanin is a 24–amino acid peptide naturally produced by the mitochondria—the cell’s energy centers—and discovered for its protective effects on neurons. Research shows that Humanin helps shield cells from oxidative stress, inflammation, and programmed cell death. It interacts with multiple cellular receptors and signaling pathways that regulate metabolism, stress resistance, and survival. By improving mitochondrial function and activating repair mechanisms, Humanin supports healthy energy production and cellular resilience. Studies have linked higher Humanin levels to improved cardiovascular, metabolic, and neuroprotective outcomes, while declining levels are associated with aging and chronic disease. Humanin has been shown to protect brain cells from Alzheimer’s-related damage, enhance insulin sensitivity, and promote overall metabolic balance. Because of these broad cytoprotective and anti-aging effects, Humanin is being studied as a potential therapeutic molecule to improve health span and delay age-related decline.

GHK with and without copper affects a large number of genes related to an organism’s response to stress and injury (tissue remodeling, anti-oxidant, anti-inflammatory, anti-pain, anti-anxiety, blood vessel growth, nerve outgrowth, anti-cancer action). Buy GHK Basic 200mg (Tripeptide-1)

Follistatin-344 is a full-sized synthetic analogue of naturally occurring Follistatin. It neutralizes the effects of myostatin, activin, and follicle stimulating hormone (FSH). In animal studies, these actions lead to increased muscle mass (both hypertrophy and hyperplasia), reduced scar formation, and inhibited certain inflammatory responses. Follistatin-344 can be altered by the body to produce other variants of Follistatin.

CJC-1295 (no DAC) (Modified GRF) is a truncated peptide analogue of growth hormone releasing hormone (GHRH). First developed in the 1980s, research studies with modGRF have shown it to improve muscle repair and growth, accelerate wound healing, strengthen bones, increase fat burning, and improve metabolism. It may also have beneficial effects on blood sugar regulation and the immune system.

CJC-1295 (no DAC) (Modified GRF) is a truncated peptide analogue of growth hormone releasing hormone (GHRH). First developed in the 1980s, research studies with modGRF have shown it to improve muscle repair and growth, accelerate wound healing, strengthen bones, increase fat burning, and improve metabolism. It may also have beneficial effects on blood sugar regulation and the immune system.

ARA-290 is variant of erythropoietin which has been shown to decrease inflammatory pathways through paracrine signalling and the innate repair receptors. Research has shown ARA-290 to help reduce HbA1c, improve cholesterol, modulate neuropathic pain and stimulate wound repair.

AOD9604 is a modified version of the hGH fragment 176-191 peptide (contains a di-sulfide bridge) and thus a derivative of human growth hormone (hGH). Originally developed as a lipolytic (fat burning) compound, AOD9604 has shown benefit in studies of heart disease, osteoarthritis/cartilage repair, and metabolic syndrome. AOD9604 stimulates lipolysis (the breakdown or destruction of fat) and inhibits lipogenesis in animal studies.